Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2001
10/03/2001CN1315374A Polypeptide-human cerebral specificity Down syndrom associated ITSN protein 14 and polynucleotide for coding it
10/03/2001CN1315368A Polypeptide-human cytokinesis regulating protein 55 and polynucleotide for coding it
10/03/2001CN1315364A Polypeptide-human natriuretic peptide receptor 13 and polynuleotide for coding it
10/03/2001CN1315361A Polypeptide-human immunoavidin 10 and polynucleotide for coding it
10/03/2001CN1315355A Polypeptide-human cytochrome b5-17 and polynucleotide for coding it
10/03/2001CN1315340A Polypeptide-low-density lipoprotein receptor 37 and polynucleotide for coding it
10/03/2001CN1315339A Polypeptide-phenylalkylamine calcium ion antagon bindin 11 and polynucleotide for coding it
10/03/2001CN1315337A Polypeptide-L1 retroelement 46 and polynucleotide for coding it
10/03/2001CN1315336A Polypeptide-CEK1-34 and polynucleotide for coding it
10/03/2001CN1315335A Polypeptide-CYP2J2-36 and polynucleotide for coding it
10/03/2001CN1315334A Polypeptide-OZF gene related protein 13 and polynucleotide for coding it
10/03/2001CN1315333A Polypeptide-GCN2-62 and polynucleotide for coding it
10/03/2001CN1315331A Polypeptide-subunit 55 of guanine nucleotide bindin and polynucleotide for coding it
10/03/2001CN1315330A Polypeptide-protein 28 containing multiple 4...3 common peptide repeated structure domain and polynucleotide for coding it
10/03/2001CA2343488A1 Test methods and devices
10/03/2001CA2342683A1 Test methods and devices
10/02/2001US6297364 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
10/02/2001US6297361 Use of histidine decarboxylase immunoreactivity to detect human cancer
10/02/2001US6297359 Polypeptide for use in the treatment of diabetes, dietetics, hypertension and premature atherosclerosis
10/02/2001US6297213 Osteogenic devices
10/02/2001US6297053 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
10/02/2001US6297049 Methods and compositions for ameliorating the symptoms of sepsis
10/02/2001US6297041 MN gene and protein
10/02/2001US6297040 Enzymatic polypeptide for the conversion of chitin to chitosan
10/02/2001US6297039 Amps from Streptococcus pneumoniae
10/02/2001US6297036 YAK-1 related serine/threonine protein kinase-HTLAR33
10/02/2001US6297028 IL-2R-associated polypeptide and DNA molecules coding therefor
10/02/2001US6296855 17-KDA Brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
10/02/2001US6296851 For screening antibiotics
10/02/2001US6296850 Apoptosis-related compounds and their use
10/02/2001US6296849 Methods and compositions including a 13kDa B. burgdorferi protein
10/02/2001US6296848 GRB2 associating polypeptides and nucleic acids encoding therefor
10/02/2001US6296846 Induced tolerance to xenografts
10/02/2001CA2020668C Fused or hybrid protein comprising viral antigen and lymphokine
10/02/2001CA2001720C Membrane affinity apparatus and purification methods related thereto
09/2001
09/27/2001WO2001071468A1 A method and system for using a new bus identifier resulting from a bus topology change
09/27/2001WO2001071358A1 Method of screening for inhibitors of osteopontin
09/27/2001WO2001071352A2 Compositions associated with complex formation
09/27/2001WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
09/27/2001WO2001071004A2 Proteases
09/27/2001WO2001070984A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
09/27/2001WO2001070983A1 A novel polypeptide, a human prostate specific membrane antibody proteine 9 and the polynucleotide encoding the polypeptide
09/27/2001WO2001070978A2 Polypeptides and nucleic acids encoding same
09/27/2001WO2001070977A2 Fibroblast growth factor receptor-like molecules and uses thereof
09/27/2001WO2001070975A1 Novel melanin concentrating hormone receptor
09/27/2001WO2001070955A2 Identification of essential genes in prokaryotes
09/27/2001WO2001070952A1 Human gata-5 transcription factor
09/27/2001WO2001070818A1 Anti-c2/c2a inhibitors of complement activation
09/27/2001WO2001070817A1 Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same
09/27/2001WO2001070808A2 Angiogenesis - associated proteins, and nucleic acids encoding the same
09/27/2001WO2001070807A2 G-protein associated molecules
09/27/2001WO2001070805A2 Soluble mast cell function associated antigen (mafa) pharmaceutical compositions and methods of making and using them
09/27/2001WO2001070804A1 7 human ovarian and ovarian cancer associated proteins
09/27/2001WO2001070799A1 Novel protein having hemolytic activity and gene encoding the protein
09/27/2001WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
09/27/2001WO2001070797A1 Ligand-controlled anion channels of insects
09/27/2001WO2001070777A2 Leafy cotyledon2 genes and their uses
09/27/2001WO2001070775A2 Wnt-1 related polypeptides, and nucleic acids encoding the same
09/27/2001WO2001070771A2 Acute neuronal induced calcium binding protein type 1 ligand
09/27/2001WO2001070767A2 Therapeutic anti-melanoma compounds
09/27/2001WO2001070766A2 Therapeutic anti-cytomegalovirus compounds
09/27/2001WO2001070268A1 Pharmaceutical comprising an agent that blocks the cell cycle and an antibody
09/27/2001WO2001070267A1 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use
09/27/2001WO2001070266A2 Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2
09/27/2001WO2001070264A1 Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant
09/27/2001WO2001070261A1 Sperm factor oscillogenin
09/27/2001WO2001070260A1 Cd18-binding antibodies inhibit stenosis-related disorders
09/27/2001WO2001070255A2 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
09/27/2001WO2001070174A2 Vegf-modulated genes and methods employing them
09/27/2001WO2001019992A3 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIV ES
09/27/2001WO2001018546A3 Screening for inhibitors of 'paired helical filaments'
09/27/2001WO2001017558A3 Novel uses of mammalian ccr6 receptors and related reagents
09/27/2001WO2001016170A3 Card proteins involved in cell death regulation
09/27/2001WO2001014533A3 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans
09/27/2001WO2001012840B1 Anti-epha2 antibodies as a cancer diagnostic
09/27/2001WO2001010903A3 Proteases and protease inhibitors
09/27/2001WO2001009178A3 Human chaperone proteins
09/27/2001WO2001002430A3 Arabidopsis thaliana cdc7 and cdc27 homologs
09/27/2001WO2000057837A8 Compositions and methods for effecting the levels of cholesterol
09/27/2001US20010024816 Purified and isolated tumor necrosis factor-alpha converting enzyme, the nucleic acids that encode it, and processes for its recombination
09/27/2001US20010024813 Human dendriac and brainiac-3
09/27/2001US20010024801 Viable, biologically pure exfoliated fecal colonocytes isolated at normal ambient temperature
09/27/2001US20010024799 An isolated antibody which specifically binds purified early conception factor; determination of conception within 18-24 hours of breeding
09/27/2001US20010024795 Detecting very low concentration of a molecule by contacting a sample with a multispecific molecule capable of binding the molecule to be detected forming a complex, which is then bound by another molecule linked by a polymer to many signals
09/27/2001US20010024783 By administering a heat and RnaseH resistant antisense agent and detecting the presence in a body fluid sample of a nuclease-resistant heteroduplex of the antisense oligomer and the target RNA; detecting infective agents, pregnancy
09/27/2001US20010024650 Artery - and vein-specific proteins and uses therefor
09/27/2001US20010024648 Four monkey monoclonal antibodies 7B6, 16C10, 7C10 and 20C9 which inhibit the B7:CD28 pathway and thereby function as effeftive immunosuppressants for the treatment of autoimmune diseases and prevent organ trasplant rejection
09/27/2001US20010024647 Single chain variable region immunoglobulin (ScFv) fragment antibody that binds selectively to the active conformation of human von Willebrand Factor (vWF) and the antibody inhibits the binding of vWF to platelets
09/27/2001US20010024645 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
09/27/2001CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
09/27/2001CA2404260A1 Identification of essential genes in prokaryotes
09/27/2001CA2404216A1 Novel polypeptides, and nucleic acids encoding the same
09/27/2001CA2403809A1 Angiogenesis - associated proteins, and nucleic acids encoding the same
09/27/2001CA2403804A1 Vegf-modulated genes and methods employing them
09/27/2001CA2403684A1 Therapeutic anti-melanoma compounds
09/27/2001CA2403681A1 Therapeutic anti-cytomegalovirus compounds
09/27/2001CA2403572A1 Fibroblast growth factor receptor-like molecules and uses thereof
09/27/2001CA2403436A1 Acute neuronal induced calcium binding protein type 1 ligand
09/27/2001CA2403434A1 Human gata-5 transcription factor
09/27/2001CA2403359A1 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use
1 ... 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 ... 1494